Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic etoricoxib 90 mg vs ARCOXIA in healthy Thai volunteers (fasting)
TCTR20190125005Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of etoricoxib in pain, osteoarthritis (OA) and rheumatoid arthritis (RA) (2 arms), sponsored by International Bio Service. Primary endpoint: Primary pharmacokinetic bioequivalence. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
etoricoxib
03
Conditions
painosteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on TCTR20190125005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190125005.